Viewing Study NCT03274258


Ignite Creation Date: 2025-12-25 @ 12:01 AM
Ignite Modification Date: 2026-01-06 @ 9:24 AM
Study NCT ID: NCT03274258
Status: TERMINATED
Last Update Posted: 2025-12-03
First Post: 2017-09-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase II Trial of Nivolumab Plus Ipilimumab in Patients With Renal Medullary Carcinoma
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module